SCHEMBL840242

SCHEMBL840242

CCC(C)NC(=O)N(CCNC(=O)C(CS)CC(C)C)Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 19/20 0.38
MME P08473 14/20 0.38
AGTR2 P50052 4/20 0.33
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL839522 0.93 AGTR1 (0.38) AGTR1MME
SCHEMBL840844 0.92 AGTR1 (0.41) AGTR1MMEAGTR2
SCHEMBL840456 0.91 AGTR1 (0.41) AGTR1MME
SCHEMBL840951 0.90 AGTR1 (0.40) AGTR1MMEAGTR2
SCHEMBL840597 0.89 AGTR1 (0.43) AGTR1MMEAGTR2
SCHEMBL839269 0.89 AGTR1 (0.40) AGTR1MME
SCHEMBL841279 0.89 AGTR1 (0.42) AGTR1MMEAGTR2
SCHEMBL839995 0.89 AGTR1 (0.39) AGTR1MMEALDH1A1
SCHEMBL841048 0.89 HDAC1 (0.40) AGTR1MMEAGTR2ALDH1A1
SCHEMBL859394 0.88 AGTR1 (0.41) AGTR1MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143298-B2 Dual-acting antihypertensive agents THERAVANCE, INC. (US) 2012-03-27 US disclosed